Good Pharmacovigilance Practice
Good pharmacovigilance practice (GPvP)-minimum standard for monitoring the safety of medicines on sale to the public in the EU. It is a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union (EU). GVP apply to marketing-authorisation holders, European Medicines Agency and medicines regulatory authorities in EU Member States. They cover medicines authorised centrally via the Agency as well as medicines authorised at national level.
- MHRA inspections- marketing authorisation holders and their contractors
- Modules covering major pharmacovigilance processes
- Types of inspection
- GPvP inspection
- Signal management
Related Conference of Good Pharmacovigilance Practice
Good Pharmacovigilance Practice Conference Speakers
Recommended Sessions
- Case Report in Clinical Trials
- Pharmacokinetics and Pharmacodynamics
- PV Consultings And Bussiness Opportunity
- Adverse Drug Reactions
- Â PV Data Base Managemaent
- Case Study
- Clinical Data Management
- Drug Safety
- Entrepreneurs Investment Meet
- Good Pharmacovigilance Practice
- Growth Strategies in Pharma
- Overview of Clinical Trials and Post Marketing
- Pharmacovigilance on Biopharmaceutics
- Pharmacovigilance Risk management plans and new risk- benefit analysis tools
- Pharmacy Practices and its Challenges
- Preclinical and Clinical Trials on Various Disorders
- Regulatory Affairs